Karyopharm to Participate at Upcoming Investor Conferences
Provided By PR Newswire
Last update: Sep 3, 2024
NEWTON, Mass., Sept. 3, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate in the following investor conferences in September:
Read more at prnewswire.com
